Targeting the Tie2/Tek Receptor in Astrocytomas
- 28 February 2004
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 164 (2) , 467-476
- https://doi.org/10.1016/s0002-9440(10)63137-9
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- VEGF and the quest for tumour angiogenesis factorsNature Reviews Cancer, 2002
- The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular developmentSeminars in Cell & Developmental Biology, 2002
- Angiogenesis-dependent diseasesSeminars in Oncology, 2001
- Direct Cell Adhesion to the Angiopoietins Mediated by IntegrinsJournal of Biological Chemistry, 2001
- Expression and hypoxic regulation of angiopoietins in human astrocytomasNeuro-Oncology, 2001
- An implantable guide-screw system for brain tumor studies in small animalsJournal of Neurosurgery, 2000
- In Situ Expression of Angiopoietins in Astrocytomas Identifies Angiopoietin-2 as an Early Marker of Tumor AngiogenesisExperimental Neurology, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-ROncogene, 1998
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993